Qool Therapeutics, Inc., based in Silicon Valley, is dedicated to creating non-invasive, efficient temperature management therapies to preserve cells, slow inflammation, and improve both quality and length of life. The company's proprietary patented technology is designed to provide a safe, simpler, and faster option for patients compared to other current competitive devices.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/28/17 | $8,000,000 | Series A-1 |
BioPacific Investors BrilliMedical International TAMPCAP Western Technology Investment Zhongji Holdings | undisclosed |
